Market Research Report
Drug-eluting Stent Market in Europe 2011-2015
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||239345|
|Published||Content info||36 Pages
|Drug-eluting Stent Market in Europe 2011-2015|
|Published: April 25, 2012||Content info: 36 Pages||
This publication has been discontinued on November 12, 2015.
TechNavio's analysts forecast the Drug-eluting Stent market in Europe to grow at a CAGR of 4.3 percent over the period 2011-2015. One of the key factors contributing to this market growth is the high prevalence of cardiovascular diseases in the region. The Drug-eluting Stent market in Europe has also been witnessing the trend of formation of strategic alliances among vendors. However, the decline in the average price of drug-eluting stent could pose a challenge to the growth of this market.
TechNavio's report, the Drug-eluting Stent Market in Europe 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on Europe; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Boston Scientific Corp., Abbott Vascular, Medtronic Inc., and Cordis Corp.